Representative Director, ASKA Pharmaceutical Holdings CO., Ltd.
Other assets (est.): the sum of each year's after-tax income (pay + dividends in own name − estimated taxes and social insurance) and dividends retained by asset-management companies (less about 20% corporate tax), for the years we have data. Spending, real estate, donations and savings from earlier years are not reflected.
| Company | Held by | Shares | Stake | Price | Value | Dividends |
|---|---|---|---|---|---|---|
| ASKA Pharmaceutical Holdings CO., Ltd. 4886 · FY ending Mar 2026 · Representative Director |
Own name | 707,000 | 2.49% | ¥2,360 | ¥1.7B | ¥42.4M |
| ZENKOKU HOSHO Co.,Ltd 7164 · FY ending Mar 2026 · Senior Managing Director |
Own name | 56,530 | — | ¥3,144 | ¥178M | ¥6.8M |